Sign in

CIK 0001650664 · Non-accelerated filer<br>Smaller reporting company

Editas Medicine, Inc.

Sign in to watch
Ticker
EDIT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464097528
Phone
617-401-9000
Business address
11 HURLEY ST., CAMBRIDGE, MA, 02141
  1. 3 Insider Initial Statement of Ownership
  2. CT ORDER Other Confidential Order
  3. SC 13G Stake Amended Statement of Ownership
  4. SC 13G Stake Amended Statement of Ownership
  5. 8-K Event Executive or director change
  6. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  7. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  8. 4 Grant or award CEO acquired 20,000 shares (grant or award)
  9. 4 Open-market sale CEO sold 5,193 shares at $25.83 ($134,135)
  10. 4 Grant or award CEO acquired 8,283 shares (grant or award)
  11. 10-Q Report Quarterly Report
  12. 8-K Event Results of operations
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 8-K Event Executive or director change · Shareholder vote results
  19. 10-Q Report Quarterly Report
  20. 8-K Event Results of operations

Page 22 of 37 · 731 filings